Index of reports
> Cases with Extrapyramidal Disorder (31)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include extrapyramidal disorder. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 31 Next >>
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Possible Invega side effects in 57 year old female
Reported by a physician from Korea, Republic of on 2012-07-20
Patient: 57 year old female
Reactions: Agitation, Extrapyramidal Disorder, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2009-06-17
Invega
Administration route: Oral
Lamictal
Indication: Bipolar Disorder
Lamictal
Indication: Schizoaffective Disorder
Invega
Administration route: Oral
Indication: Psychotic Disorder
Lamictal
Start date: 2009-08-01
Lamictal
Start date: 2009-08-01
Other drugs received by patient: Benztropine Mesylate; Xanax; Propranolol Hydrochloride; Wellbutrin
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-03
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Invega side effects in male
Reported by a physician from United States on 2012-06-26
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Invega side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient:
Reactions: Extrapyramidal Disorder
Drug(s) suspected as cause:
Invega
Possible Invega side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Possible Invega side effects in male
Reported by a physician from United States on 2012-05-31
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: male
Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Indication: Major Depression
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Indication: Bipolar Disorder
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Indication: Schizophrenia, Paranoid Type
Start date: 2010-04-07
End date: 2011-02-02
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Zyprexa
Indication: Schizophrenia
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Dosage: every 4 to 6 weeks
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Possible Invega side effects in 20 year old male
Reported by a physician from United States on 2012-04-06
Patient: 20 year old male
Reactions: Extrapyramidal Disorder
Drug(s) suspected as cause:
Invega
Possible Invega side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: male
Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension
Drug(s) suspected as cause:
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Bipolar Disorder
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Schizophrenia, Paranoid Type
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2009-01-01
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2010-04-01
End date: 2010-08-01
Risperdal
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-07-07
End date: 2011-02-02
Risperdal Consta
Dosage: ndc 050468-306
Start date: 2010-04-07
End date: 2011-02-02
Risperdal Consta
Start date: 2009-01-01
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2008-05-01
End date: 2009-11-01
Risperdal Consta
Dosage: every 4 to 6 weeks
Indication: Major Depression
Start date: 2010-01-01
End date: 2010-01-01
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Zyprexa
Indication: Schizophrenia
Cogentin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-12-11
Risperdal Consta
Start date: 2010-05-01
End date: 2010-10-01
Possible Invega side effects in 55 year old male
Reported by a physician from United States on 2012-03-30
Patient: 55 year old male
Reactions: Extrapyramidal Disorder, Repetitive Speech
Drug(s) suspected as cause:
Invega
Administration route: Oral
Start date: 2012-01-01
End date: 2012-01-01
Invega
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2012-01-01
End date: 2012-01-01
Invega
Administration route: Oral
Start date: 2012-01-01
End date: 2012-01-01
Other drugs received by patient: Metformin HCL; Depakote; Klonopin
Possible Invega side effects in female
Reported by a physician from Turkey on 2012-03-23
Patient: female
Reactions: Extrapyramidal Disorder, Parkinsonism
Adverse event resulted in: death
Drug(s) suspected as cause:
Amisulpride
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Schizophrenia
End date: 2012-02-28
Valproate Sodium
Indication: Product Used FOR Unknown Indication
Possible Invega side effects in 28 year old male
Reported by a consumer/non-health professional from Japan on 2012-03-21
Patient: 28 year old male
Reactions: Phobia, Cluttering, Hallucination, Auditory, Delusion, Myalgia, Weight Increased, Fatigue, Anger, Drug Effect Decreased, Dystonia, Blepharospasm, Hypoaesthesia, Convulsion, Aggression, Irritability, Panic Attack, Insomnia, Ocular Hyperaemia, Nervous System Disorder, Tardive Dyskinesia, Withdrawal Syndrome, Extrapyramidal Disorder
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Risperdal
Administration route: Oral
Indication: Schizophrenia
End date: 2011-02-15
Risperdal
Administration route: Oral
Invega
Administration route: Oral
Risperdal
Administration route: Oral
Invega
Administration route: Oral
Start date: 2011-02-19
Risperdal
Administration route: Oral
Start date: 2011-02-21
Chlorpromazine HCL
Invega
Administration route: Oral
Indication: Schizophrenia
Invega
Administration route: Oral
Invega
Administration route: Oral
Start date: 2011-02-16
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Other drugs received by patient: Clonazepam; Artane; Dogmatyl; Tegretol
Possible Invega side effects in 7 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: 7 year old female
Reactions: Catatonia, Extrapyramidal Disorder, Staring, Hypersomnia, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in male
Reported by a physician from United States on 2012-02-03
Patient: male, weighing 78.9 kg (173.6 pounds)
Reactions: Extrapyramidal Disorder, Treatment Noncompliance
Drug(s) suspected as cause:
Invega Sustenna
Indication: Product Used FOR Unknown Indication
Invega
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2011-09-01
End date: 2011-11-28
Possible Invega side effects in female
Reported by a physician from Japan on 2011-12-19
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Femur Fracture, Extrapyramidal Disorder, Fall
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-09-22
Invega
Administration route: Oral
Start date: 2011-07-25
End date: 2011-09-21
Other drugs received by patient: Rozerem; Akineton; Nitrazepam; Rabeprazole Sodium
Possible Invega side effects in 57 year old female
Reported by a physician from Korea, Republic of on 2011-12-12
Patient: 57 year old female
Reactions: Agitation, Extrapyramidal Disorder, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Lamictal
Start date: 2009-08-01
Risperdal
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2009-06-17
Lamictal
Start date: 2009-08-01
Lamictal
Indication: Bipolar Disorder
Invega
Administration route: Oral
Indication: Psychotic Disorder
Lamictal
Indication: Schizoaffective Disorder
Other drugs received by patient: Propranolol HCL; Benztropine Mesylate; Wellbutrin; Xanax
Possible Invega side effects in male
Reported by a physician from United States on 2011-12-09
Patient: male
Reactions: Extrapyramidal Disorder
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizophrenia
Start date: 2011-01-01
Invega
Administration route: Oral
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-01-01
End date: 2011-11-01
Other drugs received by patient: Cogentin
Possible Invega side effects in male
Reported by a physician from United States on 2011-11-30
Patient: male, weighing 74.8 kg (164.6 pounds)
Reactions: Akathisia, Flat Affect, Social Phobia, Nasal Congestion, Compulsions, Aggression, Dyspnoea Exertional, Illogical Thinking, Extrapyramidal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Bipolar Disorder
Invega
Administration route: Oral
Start date: 2009-02-01
End date: 2011-08-24
Risperdal
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-08-24
End date: 2011-09-29
Other drugs received by patient: Propranolol; Synthroid; Zoloft
Possible Invega side effects in female
Reported by a physician from Belgium on 2011-11-18
Patient: female
Reactions: Confusional State, Dehydration, Urinary Tract Infection, Extrapyramidal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in female
Reported by a physician from Japan on 2011-11-17
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Fracture, Extrapyramidal Disorder, Fall
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2011-09-22
Invega
Administration route: Oral
Start date: 2011-07-25
End date: 2011-09-21
Other drugs received by patient: Akineton; Rozerem; Rabeprazole Sodium; Nitrazepam
Possible Invega side effects in 28 year old male
Reported by a consumer/non-health professional from Japan on 2011-11-14
Patient: 28 year old male
Reactions: Phobia, Cluttering, Hallucination, Auditory, Delusion, Weight Increased, Myalgia, Fatigue, Anger, Blepharospasm, Dystonia, Hypoaesthesia, Aggression, Convulsion, Panic Attack, Ocular Hyperaemia, Insomnia, Nervous System Disorder, Withdrawal Syndrome, Extrapyramidal Disorder, Tardive Dyskinesia
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-02-19
Invega
Administration route: Oral
Risperdal
Administration route: Oral
Start date: 2011-02-21
Risperdal
Administration route: Oral
Invega
Administration route: Oral
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Schizophrenia
End date: 2011-02-15
Invega
Administration route: Oral
Start date: 2011-02-16
Chlorpromazine HCL
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Tegretol; Clonazepam; Artane; Dogmatyl
Possible Invega side effects in female
Reported by a physician from Belgium on 2011-11-02
Patient: female
Reactions: Hospitalisation, Extrapyramidal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2011-11-02
Patient: female
Reactions: Weight Increased, Prolactinoma, Extrapyramidal Disorder, Injury
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Ibuprofen; Lexapro
Possible Invega side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-02
Patient: female
Reactions: Extrapyramidal Disorder
Drug(s) suspected as cause:
Invega
Possible Invega side effects in 64 year old female
Reported by a physician from Korea, Republic of on 2011-10-28
Patient: 64 year old female
Reactions: Extrapyramidal Disorder, Delusion, Psychotic Behaviour
Drug(s) suspected as cause:
Invega
Dosage: for one month
Administration route: Oral
Invega
Administration route: Oral
Invega
Administration route: Oral
Indication: Schizophrenia
Possible Invega side effects in female
Reported by a lawyer from United States on 2011-10-25
Patient: female
Reactions: Weight Increased, Prolactinoma, Injury, Extrapyramidal Disorder
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Ibuprofen; Lexapro
Possible Invega side effects in 57 year old female
Reported by a physician from Korea, Republic of on 2011-10-24
Patient: 57 year old female
Reactions: Agitation, Extrapyramidal Disorder, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Psychotic Disorder
Start date: 2009-06-01
Invega
Administration route: Oral
Indication: Psychotic Disorder
Lamictal
Indication: Schizoaffective Disorder
Invega
Administration route: Oral
Lamictal
Start date: 2009-08-01
Lamictal
Start date: 2009-08-01
Lamictal
Indication: Bipolar Disorder
Other drugs received by patient: Xanax; Wellbutrin
Possible Invega side effects in 64 year old female
Reported by a physician from Korea, Republic of on 2011-10-24
Patient: 64 year old female
Reactions: Extrapyramidal Disorder, Psychotic Behaviour, Delusion
Drug(s) suspected as cause:
Invega
Administration route: Oral
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Invega
Dosage: for one month
Administration route: Oral
Page 1 Next >>
|